Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia.
dc.contributor.author | Polampalli, S | |
dc.contributor.author | Choughule, A | |
dc.contributor.author | Prabhash, K | |
dc.contributor.author | Amare, P | |
dc.contributor.author | Baisane, C | |
dc.contributor.author | Kabre, S | |
dc.contributor.author | Mahadik, S | |
dc.contributor.author | Shinde, S | |
dc.contributor.author | Nair, R | |
dc.contributor.author | Banavali, S | |
dc.date.accessioned | 2013-01-16T10:35:15Z | |
dc.date.available | 2013-01-16T10:35:15Z | |
dc.date.issued | 2011-01 | |
dc.description.abstract | Background: Patients with a presence of Promyelocytic Leukemia-Retinoic Acid Receptor Alpha (PML-RARA) genes rearrangement predict a favorable response to all-trans retinoic acid (ATRA), and a significant improvement in survival. Therefore, establishing the presence of PML-RARA rearrangement is important for optimal patient management. Aim: The objective of this study is to compare and assess the role of fluorescent in situ hybridization (FISH) and reverse transcriptase polymerase chain reaction (RT-PCR) in the diagnosis and long-term monitoring of Acute Promyelocytic Leukemia (APL). Materials and Methods: We compared 145 samples received at different interval of times to analyze the sensitivity of RT-PCR and FISH. Results: The failure rate for RT-PCR was 4% at baseline, 13% at induction, and 0% at the end of consolidation. And for FISH it was 8% at baseline, 38% at induction, and 66% at the end of consolidation. The predictive values of relapse in the patients who were positive and negative by RT-PCR, at the end of induction, were 60 % and 3%, respectively, and at end of consolidation it was 67 % and 4%, respectively. On the other hand the predictive values of relapse in patients who were positive and negative by FISH at end of induction were 57 % and 6%, respectively; while at end of consolidation it was 14% who were negative by FISH. Conclusion: Both RT-PCR and FISH are important for the diagnosis of APL cases, as both techniques complement each other in the absence or failure of any one of them. However, RT-PCR is more sensitive than FISH for the detection of minimal residual disease in the long-term monitoring of these patients. The present study shows that the predictive value of relapse is more associated with minimal residual disease (MRD) results by RT-PCR than that by FISH. | en_US |
dc.identifier.citation | Polampalli S, Choughule A, Prabhash K, Amare P, Baisane C, Kabre S, Mahadik S, Shinde S, Nair R, Banavali S. Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia. Indian Journal of Cancer. 2011 Jan-Mar; 48(1): 60-67. | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/144413 | |
dc.language.iso | en | en_US |
dc.source.uri | https://www.indianjcancer.com/article.asp?issn=0019-509X;year=2011;volume=48;issue=1;spage=60;epage=67;aulast=Polampalli | en_US |
dc.subject | Reverse transcriptase polymerase chain reaction | en_US |
dc.subject | fluorescent in situ hybridization | en_US |
dc.subject | acute promyelocytic leukemia | en_US |
dc.subject.mesh | Antineoplastic Agents --therapeutic use | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | In Situ Hybridization, Fluorescence | |
dc.subject.mesh | Leukemia, Promyelocytic, Acute --diagnosis | |
dc.subject.mesh | Leukemia, Promyelocytic, Acute --drug therapy | |
dc.subject.mesh | Leukemia, Promyelocytic, Acute --genetics | |
dc.subject.mesh | Neoplasm, Residual --diagnosis | |
dc.subject.mesh | Neoplasm, Residual --drug therapy | |
dc.subject.mesh | Neoplasm, Residual --genetics | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | RNA, Messenger --genetics | |
dc.subject.mesh | Reverse Transcriptase Polymerase Chain Reaction | |
dc.subject.mesh | Treatment Outcome | |
dc.subject.mesh | Tretinoin --therapeutic use | |
dc.title | Role of RT-PCR and FISH in diagnosis and monitoring of acute promyelocytic leukemia. | en_US |
dc.type | Article | en_US |